Exendin-4 Potentiates Insulinotropic Action Partly via Increasing β-Cell Proliferation and Neogenesis and Decreasing Apoptosis in Association With the Attenuation of Endoplasmic Reticulum Stress in Islets of Diabetic Rats
Authors:
- Young Sup KimYKYoung Sup Kim
- Il Sung AhnIAIl Sung Ahn
- Da Sol KimDKDa Sol Kim
- Suna KangSKSuna Kang
- Snag Mee HongSHSnag Mee Hong
- Sunmin ParkSunmin Park
- 1 January 2009
- journal article
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 111 (4) , 361-371
Abstract
Exendin-4, a long-acting glucagon-like peptide-1-receptor agonist, is known to enhance beta-cell function, but the active mechanism by which it modulates beta-cell mass still remains unclear. We investigated what the long-term effects of exendin-4 (300 pmol/kg body weight per day) on beta-cell function and mass would be in 90% pancreatectomized (Px) Sprague Dawley rats; half of whom were intraperitoneally injected with streptozotocin (STZ, 20 mg/kg body weight) and half of whom were not. Exendin-4 improved glucose tolerance by elevating serum insulin levels in both STZ-treated and untreated Px rats. At hyperglycemic clamp, STZ attenuated both first and second phase insulin secretion in STZ- and saline-treated Px rats, but exendin-4 incompletely reversed the attenuation. Since STZ mostly removed the remaining beta-cells by increasing apoptosis after Px, their regeneration was initiated through neogenesis, which was determined by the number of beta-cells budding from pancreatic duct layers and small clusters. Exendin-4 enhanced beta-cell proliferation and neogenesis in STZ-treated and -untreated Px rats and reduced beta-cell apoptosis partly by attenuating the expression of endoplasmic reticulum stress-response genes such as X-box-binding protein-1, activating transcription factor (ATF)-4, ATF6, and C/EBP-homologous protein. In conclusion, exendin-4 improved glycemic control by potentiating beta-cell function and increasing beta-cell mass by increasing beta-cell neogenesis and proliferation and by decreasing apoptosis in diabetic rats.Keywords
This publication has 44 references indexed in Scilit:
- Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunctionJournal of Molecular and Cellular Cardiology, 2009
- Antioxidants reduce endoplasmic reticulum stress and improve protein secretionProceedings of the National Academy of Sciences, 2008
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007
- In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetesGene Therapy, 2007
- ER stress: Can the liver cope?Journal of Hepatology, 2006
- Enhanced expression of PDX-1 and Ngn3 by exendin-4 during β cell regeneration in STZ-treated miceBiochemical and Biophysical Research Communications, 2004
- IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNANature, 2002
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001
- Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).Journal of Clinical Investigation, 1996
- Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus RevisitedPathology and Immunopathology Research, 1985